The genetic regulatory signature of type 2 diabetes in human skeletal muscle
Citations Over TimeTop 10% of 2016 papers
Abstract
Type 2 diabetes (T2D) results from the combined effects of genetic and environmental factors on multiple tissues over time. Of the >100 variants associated with T2D and related traits in genome-wide association studies (GWAS), >90% occur in non-coding regions, suggesting a strong regulatory component to T2D risk. Here to understand how T2D status, metabolic traits and genetic variation influence gene expression, we analyse skeletal muscle biopsies from 271 well-phenotyped Finnish participants with glucose tolerance ranging from normal to newly diagnosed T2D. We perform high-depth strand-specific mRNA-sequencing and dense genotyping. Computational integration of these data with epigenome data, including ATAC-seq on skeletal muscle, and transcriptome data across diverse tissues reveals that the tissue-specific genetic regulatory architecture of skeletal muscle is highly enriched in muscle stretch/super enhancers, including some that overlap T2D GWAS variants. In one such example, T2D risk alleles residing in a muscle stretch/super enhancer are linked to increased expression and alternative splicing of muscle-specific isoforms of ANK1.
Related Papers
- → Estimating the causal tissues for complex traits and diseases(2017)240 cited
- → Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS(2012)55 cited
- Coanalysis of GWAS with eQTLs reveals disease-tissue associations.(2012)
- → rs2072135, a low‐penetrance variant for chronic lymphocytic leukaemia?(2013)2 cited
- → P3‐016: Overlap of gwas loci and expression quantitative trait loci (eQTL) in Alzheimer's disease(2015)